Back to Directory Sharon Appelbaum Nachman Email sharon.nachman@stonybrook.edu Institution SUNY Health Science Center at Stony Brook Title Investigator Request an Update Affiliated Studies IMPAACT 2036: Phase I/II Study of the Safety, Tolerability, Pharmacokinetics, and antiviral activity of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed HIV-Infected Children >2 to <12 years of age and weighing >10 kgs and <50 kgs Research Area Treatment Study Status In Development P1024: Evaluation of the Immunogenicity of Pneumococcal Conjugate Vaccine DAIDS Number 10269 Research Area Other Study Status Concluded Locality Not Applicable P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY DAIDS Number 10765 Research Area Other Study Status Concluded P1041: Efficacy of Isoniazid to prevent TB DAIDS Number 10047 Research Area Other Study Status Participants Off Study and Primary Analysis Completed P1086: Phase II Study in HIV Positive Pregnant Women to Assess the Safety and Immunogen DAIDS Number 10835 Research Area Other Study Status Concluded Show All
IMPAACT 2036: Phase I/II Study of the Safety, Tolerability, Pharmacokinetics, and antiviral activity of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed HIV-Infected Children >2 to <12 years of age and weighing >10 kgs and <50 kgs Research Area Treatment Study Status In Development
P1024: Evaluation of the Immunogenicity of Pneumococcal Conjugate Vaccine DAIDS Number 10269 Research Area Other Study Status Concluded Locality Not Applicable
P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY DAIDS Number 10765 Research Area Other Study Status Concluded
P1041: Efficacy of Isoniazid to prevent TB DAIDS Number 10047 Research Area Other Study Status Participants Off Study and Primary Analysis Completed
P1086: Phase II Study in HIV Positive Pregnant Women to Assess the Safety and Immunogen DAIDS Number 10835 Research Area Other Study Status Concluded
